22h
Barchart on MSNIs Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, ...
6h
Daily Maverick on MSNNikki Brighton’s verdant way with uncultivated foodWe asked Nikki Brighton to explain why humans should consider a diet that is very green and close to home — the diet of a ...
17hon MSN
Fairleigh Dickinson earned the first NCAA Tournament bid in school history after beating Chicago State 90-61 in the Northeastern Conference Tournament semifinals.
Kimberly Sullivan, the woman accused of holding her stepson captive in a locked room for more than two decades, was freed on ...
Leading the way will be Binford, an All-Idaho second-team selection who played in all 23 games last season with 79 at-bats ...
Eli Lilly has raised its revenue guidance for 2024 by $3 billion, after reporting strong growth for tirzepatide in diabetes and obesity, fuelled by the end of supply constraints for starting doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results